1180553

AvKARE — FEI 3007255004

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 23, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pulaski, TN (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)